Joel Rothman

Joel Rothman

Corporate Officer/Principal at EQUILLIUM, INC.

Net worth: 40 298 $ as of 2024-06-29

55 year
Health Technology
Commercial Services
Consumer Services

Profile

Joel M.
Rothman
is currently the Chief Development Officer at Equillium, Inc. Prior to his current position, he held the role of Vice President at Cytokinetics, Inc. and Raptor Pharmaceuticals, Inc. He also served as the Director-Regional Operations at ICON Clinical Research, Inc. Mr. Rothman has a background in undergraduate and graduate studies from Albright College and the Massachusetts Institute of Technology.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-01-01 58,150 ( 0.16% ) 40 298 $ 2024-06-29

Joel Rothman active positions

CompaniesPositionStart
EQUILLIUM, INC. Corporate Officer/Principal 2020-12-31
All active positions of Joel Rothman

Former positions of Joel Rothman

CompaniesPositionEnd
CYTOKINETICS, INCORPORATED Corporate Officer/Principal 2018-08-31
Corporate Officer/Principal 2016-12-31
Corporate Officer/Principal 2004-06-30
Corporate Officer/Principal -
See the detail of Joel Rothman's experience

Training of Joel Rothman

Albright College Undergraduate Degree
Massachusetts Institute of Technology Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joel Rothman's experience

Connections

35

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
EQUILLIUM, INC.

Health Technology

CYTOKINETICS, INCORPORATED

Health Technology

Private companies3

Health Technology

Commercial Services

Health Technology

See company connections